Business Wire

Norge Mining Signs IBU-tec advanced materials AG Agreement Giving Access to the World’s Largest Phosphate Reserves

Share

IBU-tec advanced materials AG and the Anglo-Norwegian mining company Norge Mining Ltd. have signed a strategic cooperation letter of intent. With this agreement, IBU-tec will have access to the largest phosphate reserves in the world. IBU-tec sustainably secures raw materials for the production of battery materials as part of its long-term growth strategy. These raw materials can be used in batteries for e-mobility, among other things. Several international vehicle manufacturers use such raw materials in their lithium iron phosphate (LFP) batteries. The agreement reached with Norge Mining means that IBU-tec’s needs can now be met in large quantities with the corresponding precursor products from a Norwegian source.

At approximately 70 billion tons, Norge Mining controls the worlds’ largest phosphate rock deposits. In addition to the phosphate reserves, both titanium and vanadium can be made market available in the near future, sourced both in and for the benefit of Western European economies. IBU-tec and Norge Mining will work together with phosphate-containing materials in the manufacture of precursor products.

The first phase will consist of exchanging information regarding industrial production planning for the various precursor products obtained from southern Norway’s raw materials mines. IBU-tec’s production expertise, specifically regarding product customization ability with LFP accumulators is of great production importance in addition to the ability to supply IBU-tec with Norwegian precursor products.

Given the volatile current supply situation, as the only European manufacturer of LFP battery materials to date, IBU-tec is taking seriously the responsibility of regionally securing the supply vital raw materials. LFP batteries are increasingly being used in electromobility and stationary energy storage, among other things. Thus forming an important part of the implementation of the global energy transition.

Ulrich Weitz, CEO of IBU-tec: “Safe, reliable and, last but not least, sustainable sources of raw materials are a key requirement for large-volume LFP battery materials production, especially in the current economic environment. The cooperation with Norge Mining ensures that we can obtain iron phosphate from European sources for years to come. The agreement also enables us to customize precursor products for battery production according to our requirements. This allows us to comprehensively control material composition, thus ensuring that our customers receive high-quality IBUvolt® for the production of high-performance battery cells.”

Michael Wurmser, founder of Norge Mining, explains the future of cooperation with IBU-tec: “As a critical raw materials company, we provide the basis for the clean energy and mobility transition. It is estimated that the number of electric vehicles registered worldwide will increase to around 500 million by 2040. Countless batteries are required for this. Against this background, we are pleased with our forward-looking IBU-tec partnership to scale the reliable production of European origin LFP cells, meeting the growing requirements for the European market and beyond. The partnership also fully complies with current regulatory developments such as the Supply Chain Act or the 17 Sustainable Development Goals of the United Nations.”

About IBU-tec

The IBU-tec Group develops and produces innovative materials of the highest quality for industry. It combines unique, partly patent-protected technology of thermal process engineering with the process and material know-how of around 250 highly qualified employees.

Its own products include LFP battery material, which is an important component of batteries for electromobility and stationary energy storage, as well as solutions for air purification, resource conservation and the reduction of plastic packaging. IBU-tec is thus well positioned in the long term for global megatrends – especially regarding climate and environmental protection – and has an international customer base ranging from innovative medium-sized companies to global corporations.

About Norge Mining

Norge Mining Ltd. is an Anglo-Norwegian resource company focused on sustainable mineral exploration in Norway. The Company’s initial mineral resource estimates from the Bjerkreim Exploration Project have confirmed world-class deposits of the critical EU commodities vanadium, titanium and phosphate. The European origin of these minerals is of considerable strategic importance for the climate-neutral and independent supply of western industrialized countries within the framework of safe and reliable supply chains, thus helping to ensure an easier sustainable energy and mobility transition as well as food security.

Norge Mining holds 61 exploration licenses totaling more than 560 square kilometers in southwestern Norway. The Company is currently conducting an exploration program that builds on previous studies by the Norwegian Geological Survey (NGU). It is Norge Mining’s stated goal to become a significant, sustainable and strategically important exploration and mining company with a focus on Norway.

Founded in November 2018, the company is headquartered in the UK and has 100% ownership of its Norwegian subsidiary, Norge Mineraler AS.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

IBU-tec advanced materials AG
Dr. Stefan Steck
Public & Investor Relations

t +49 3643 8649-51
IR@ibu-tec.de
www.ibu-tec.de

Norge Mining Ltd.
Mark Court / George Cleary
Buchanan Communications

+44 (0) 20 7466 5000
norgemining@buchanan.uk.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye